Why the study?
Does systemic anticoagulation prevent embolism in patients with decreased left ventricular function?
Does systemic anticoagulation prevent embolism in patients with decreased left ventricular function?
Answers are grounded in this paper and cite their sources.
Due to the high incidence of intracavitary thrombus and embolism in patients with decreased left ventricular function, systemic anticoagulation (INR 2.0-3.0) is justified in patients with dilated cardiomyopathy.
Intracavitary thrombus is noted in 11-44% of patients with idiopathic delayed cardiomyopathy, and the incidence of embolism is 11-20%. The incidence of intracavitary thrombus formation after acute anterior myocardial infarction is 21-41%. The risk of embolism in all patient with acute anterior myocardial infarction is 2-6%; protruding or mobile thrombi carry a risk of embolization. Systemic anticoagulation is justified in patients with dilated cardiomyopathy (international normalized ratio 2.0-3.0).
No takes yet. Share an insight, caveat, or question.
Wilensky et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: